Finance

Lists
AURX:OTCMKTS
Nuo Therapeutics Inc
$1.03
+3.00%
(+0.030) 1D
Aug 21, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AURX...
Open
$1.02
High
$1.03
Low
$1.02
Mkt. cap
49.89M
Avg. vol.
1.65K
Volume
1.20K
52-wk high
$3.23
52-wk low
$0.77
EPS
-$0.04
Beta
-4.55
Shares outstanding
48.43M
No. of employees
10
Open
$1.02
High
$1.03
Low
$1.02
Mkt. cap
49.89M
Avg. vol.
1.65K
Volume
1.20K
52-wk high
$3.23
52-wk low
$0.77
EPS
-$0.04
Beta
-4.55
Shares outstanding
48.43M
No. of employees
10
About Nuo Therapeutics Inc
CEO-
Employees10
Founded1998
HeadquartersHouston, Texas, United States
SectorBiotechnology
Websitenuot.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.03M
1.10M
1.30M
1.77M
Cost of goods sold
406.72K
408.46K
452.39K
598.96K
Cost of revenue
406.72K
408.46K
452.39K
598.96K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.17M
1.27M
1.30M
1.34M
Operating expense
1.17M
1.27M
1.30M
1.34M
Total operating expenses
1.57M
1.68M
1.75M
1.94M
Operating income
-540.14K
-579.34K
-446.47K
-166.55K
Other non operating income
1.81K
1.63K
3.28K
3.02K
EBT including unusual items
-537.92K
-578.48K
-618.47K
-277.60K
EBT excluding unusual items
-537.92K
-578.48K
-618.47K
-277.60K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-537.92K
-578.48K
-618.47K
-277.60K
Net profit margin
-52.12%
-52.74%
-47.50%
-15.69%
Earnings per share
-
-0.01
-
-
Interest and investment income
409.00
-
-
-
Interest expense
-
-771.00
-175.28K
-114.07K
Net interest expenses
409.00
-771.00
-175.28K
-114.07K
Depreciation and amortization charges
-
-
-
-
EBITDA
-516.99K
-555.43K
-424.21K
-140.35K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps